See more : Suyog Gurbaxani Funicular Rope (SGFRL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Reliq Health Technologies Inc. (RQHTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reliq Health Technologies Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Ningbo ZhongDa Leader Intelligent Transmission Co., Ltd. (002896.SZ) Income Statement Analysis – Financial Results
- Cullen/Frost Bankers, Inc. (CFR-PB) Income Statement Analysis – Financial Results
- JHS Svendgaard Laboratories Limited (JHS.BO) Income Statement Analysis – Financial Results
- DiamondRock Hospitality Company (DRH-PA) Income Statement Analysis – Financial Results
- Baird Medical Investment Holdings Limited (BDMD) Income Statement Analysis – Financial Results
Reliq Health Technologies Inc. (RQHTF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.reliqhealth.com
About Reliq Health Technologies Inc.
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.55M | 1.46M | 1.14M | 181.91K | 2.27M | 182.65K | 536.20K | 31.62K | 29.74K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
| Cost of Revenue | 3.25M | 7.26M | 7.52M | 5.84M | 12.24M | 960.12K | 544.48K | 1.85K | 93.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.30M | -5.80M | -6.38M | -5.66M | -9.97M | -777.47K | -8.28K | 29.77K | -63.58K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
| Gross Profit Ratio | 61.99% | -396.52% | -558.27% | -3,112.71% | -439.17% | -425.65% | -1.54% | 94.15% | -213.83% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
| Research & Development | 2.22M | 1.73M | 1.72M | 5.15M | 1.42M | 719.41K | 447.23K | 270.20K | 432.89K | 510.83K | 172.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.03M | 10.11M | 8.82M | 7.33M | 12.00M | 1.80M | 1.84M | 4.06M | 331.33K | 517.42K | 398.62K | 812.67K | 769.08K | 663.98K | 44.57K | 0.00 | 0.00 |
| Selling & Marketing | 492.65K | 515.70K | 353.48K | 274.48K | 381.68K | 311.50K | 354.60K | 211.65K | 11.24K | 10.30K | 11.67K | 42.26K | 177.38K | 31.29K | 412.00 | 0.00 | 0.00 |
| SG&A | 10.52M | 4.10M | 3.06M | 2.64M | 2.40M | 1.30M | 1.97M | 4.27M | 331.33K | 517.42K | 410.29K | 854.94K | 946.46K | 695.27K | 44.98K | 109.46K | 1.00K |
| Other Expenses | 888.82K | -5.64K | -58.35K | -34.40K | -32.97K | 189.88K | 18.25K | 0.00 | 0.00 | 0.00 | -2.02K | -3.61K | -28.09K | 1.67K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 13.63M | 5.83M | 4.84M | 7.82M | 3.82M | 2.02M | 2.42M | 4.54M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
| Cost & Expenses | 16.88M | 13.09M | 12.37M | 13.67M | 16.06M | 2.98M | 2.96M | 4.55M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
| Interest Income | 76.61K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 43.81K | 11.00 | 2.24K | 5.74K | 1.73K | 12.31K | 13.99K | 12.69K | 274.00 |
| Interest Expense | 35.28K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 0.00 | 1.17K | 813.00 | 1.11K | 698.00 | 631.00 | 123.00 | 113.00 | 0.00 |
| Depreciation & Amortization | 115.29K | 125.76K | 445.41K | 634.16K | 634.16K | 2.05K | 6.17K | 6.17K | 2.18K | 1.49K | 938.00 | 1.94K | 639.00 | 11.28K | 123.00 | 0.00 | 0.00 |
| EBITDA | -8.02M | -11.51M | -10.78M | -12.85M | -12.65M | -2.80M | -2.42M | -2.40M | -928.85K | 367.16K | 223.33K | -854.94K | -972.83K | -684.63K | -44.98K | -109.46K | -726.00 |
| EBITDA Ratio | -93.79% | -786.98% | -943.01% | -7,064.61% | -607.62% | -1,532.76% | -451.51% | -14,261.37% | 311.96% | 593.03% | 14,918.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
| Operating Income | -8.30M | -11.63M | -11.22M | -13.49M | -13.79M | -2.80M | -2.43M | -2.45M | -317.35K | -518.90K | -526.04K | -857.99K | -947.80K | -695.90K | -45.10K | -109.46K | -726.00 |
| Operating Income Ratio | -97.01% | -795.58% | -981.98% | -7,413.23% | -607.62% | -1,533.88% | -452.66% | -7,764.22% | -1,067.26% | -838.13% | -35,139.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
| Total Other Income/Expenses | 124.77K | -101.19K | 33.51K | 301.31K | -163.28K | 340.54K | -412.46K | -2.10M | -440.25K | -512.27K | -748.97K | 2.13K | -413.04K | -39.36K | 0.00 | 0.00 | 726.00 |
| Income Before Tax | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.36M | -735.26K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 4.00 | 239.11K | 2.00 | -2.05K | 3.00 | 1.00 | -2.02M | 424.09K | 884.57K | 747.99K | -79.38K | -138.88K | -8.98K | -13.99K | 96.88K | 726.00 |
| Net Income | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.22M | -735.26K | -31.11K | -96.88K | -726.00 |
| Net Income Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
| EPS | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
| EPS Diluted | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
| Weighted Avg Shares Out | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
| Weighted Avg Shares Out (Dil) | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Reliq Health Technologies, Inc. Announces that it has Engaged Wall Street Reporter for Investor Marketing
HAMILTON, Ontario, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today...
Reliq Health Technologies, Inc. Announces First Contract to Deploy its iUGO Home Solution
HAMILTON, Ontario, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today...
3 Microcap Stocks That Are Capturing Market Share
Aurora Solar Technologies is a fast grower with a new product that could further accelerate growth. GSE Systems has taken advantage of the COVID-19 caused business disruption to refocus on organic growth.
Reliq Health Technologies, Inc. Announces Launch of Multilingual Interactive Voice Recognition and New Contract in Maryland
HAMILTON, Ontario, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today...
Reliq Health Technologies, Inc. Launches New Annual Wellness Visit Product and Announces New US Contract
HAMILTON, Ontario, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has...
Reliq Health Technologies Inc. Closes Oversubscribed Private Placement
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q1 2021 Results - Earnings Call Transcript
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q1 2021 Results - Earnings Call Transcript
Reliq Health Technologies, Inc. Files Q1 FY2021 Financial Statements, Provides Corporate Update
HAMILTON, Ontario, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF ) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare announced that the interim...
Reliq Health Technologies, Inc. Issues Correction to Shareholder Webinar Date
HAMILTON, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF ) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, wishes to inform shareholders...
Source: https://incomestatements.info
Category: Stock Reports